ArticleOrphanet journal of rare diseases2025

Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS).

Karolina M Stepien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.